1.
Variables | Characteristics | n | % |
Gender | Male | 60 | 53.6% |
Female | 52 | 46.4% | |
Age (year) | ≤65 | 90 | 80.4% |
>65 | 22 | 19.6% | |
Pathological type | Adenocarcinoma | 85 | 75.9% |
Signet-ring cell carcinoma | 23 | 20.5% | |
Unknown | 4 | 3.6% | |
Staging | Ⅳ stage | 112 | 100.0% |
Differentiation degree | Poor differentiation | 71 | 63.4% |
Middle-low differentiation | 18 | 16.0% | |
Middle differentiation | 14 | 12.5% | |
Middle to well differentiation | 2 | 1.8% | |
Unknown | 7 | 6.3% | |
Lauren type | Intestinal type | 21 | 18.7% |
Diffused type | 38 | 33.9% | |
Mixed type | 20 | 17.9% | |
Unknown | 33 | 29.5% | |
MSI status | pMMR | 18 | 16.0% |
dMMR | 4 | 3.6% | |
Unknown | 90 | 80.4% | |
Her-2 status | Negative | 67 | 59.8% |
Positive | 24 | 21.4% | |
Unknown | 21 | 18.8% | |
Liver metastasis | Presence | 24 | 21.4% |
Absence | 88 | 78.6% | |
Peritoneal metastasis | Presence | 43 | 38.4% |
Absence | 69 | 61.6% | |
Retroperitoneal lymph node metastases | Presence | 14 | 12.5% |
Absence | 98 | 87.5% | |
Site of metastasis | ≤2 | 87 | 77.7% |
>2 | 25 | 22.3% |